Company intelligence / Profile preview
HDT Bio
Seattle, Washington, United Stateshdt.bio ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Phase 1
01
Overview
HDT Bio has demonstrated the ability of its AMPLIFY™/LION™ self-amplifying RNA vaccine platform to generate potent and durable immune responses with a favorable safety profile. Its COVID‑19 vaccine received emergency use authorization in some regions. The company’s technologies are being licensed for new vaccines such as malaria and are part of national pandemic preparedness initiatives. Preclinical and early clinical data show robust immunogenicity and improved stability compared to traditional mRNA platforms[1][2].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- self-amplifying RNA (repRNA)RNA vaccines/therapeutics
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →03
Partnerships
MalarVx Inc. (malaria vaccine licensing)[1][6]PROVIDENT consortium/National Institutes of Health pandemic preparedness network [2]Collaborations with academic/government partners worldwide [2]
Beyond the preview
Go deeper on HDT Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HDT Bio.